Internal Server Error

Innoplexus - About the company

Innoplexus is a series C company based in Eschborn (Germany), founded in 2011 by Gaurav Tripathi and Gunjan Bhardwaj. It operates as an AI-based life Sciences company that provides solutions for discovering and developing safer and more successful medicines by leveraging its proprietary ontosight AI search platform. Innoplexus has raised an undisclosed amount in funding from HCS Beteiligungsgesellschaft and Vc. The company has 2166 active competitors, including 143 funded and 245 that have exited. Its top competitors include companies like AbbVie, Amgen and IQVIA.

Company Details

AI-based life Sciences company that provides solutions for discovering and developing safer and more successful medicines by leveraging its proprietary ontosight AI search platform.
Social
XFacebook
Email ID
*****@innoplexus.com
Phone Number
+49 **********
Part Of
Registered Address
7th Floor, Plot No. 44, Rajiv Gandhi Infotech Park PH-1, Hinjewadi, Pune, Pune, Maharashtra, India, 411057
Key Metrics
Founded Year
2011
Location
Eschborn, Germany
Stage
Series C
Latest Funding Round
Ranked
Employee Count
176 as on May 31, 2026
Investment & Acquisitions
Similar Companies
Sign up to download Innoplexus' company profile

Innoplexus's funding and investors

Innoplexus has raised funding over 2 rounds. Its first funding round was on Dec 05, 2016. Its latest funding round was a Series C round on Apr 25, 2019 for $*****. 1 investor participated in its latest round. Innoplexus has 5 institutional investors.

Here is the list of recent funding rounds of Innoplexus:
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Apr 25, 2019
6092708
Series C
5321088
4166339
3387559
9778058
Dec 05, 2016
6007516
Seed
3931418
9535356
2133956
lockAccess funding benchmarks and valuations. Sign up today!

Innoplexus' founders and board of directors

Founder? Claim Profile
The founders of Innoplexus are Gaurav Tripathi and Gunjan Bhardwaj. Gunjan Bhardwaj is the CEO of Innoplexus.
Here are the details of Innoplexus' key team members:

Innoplexus' Board of Directors

Innoplexus's board has 4 active members. Gaurav Tripathi is part of team and Anshu Kumar, Varsha Rohani and Amit Gokul Ananpara are independent board members.
Here is the list of Innoplexus' board of directors:
Name
Type
Representing
Status
Duration
wtntqps
Team
-
Past
7y 9m
fv{muox
Team
-
Past
6y 7m
ynyxsnj
Team
-
Past
5y 2m
Independent board member
-
Current
8y 7m
iwlr{uv
Independent board member
-
Current
6y 9m
tsaurul
Independent board member
-
Current
3y 5m

Innoplexus' employee count trend

Innoplexus has 176 employees as of May 26. Here is Innoplexus's employee count trend over the years:
Employee count trend for Innoplexus
lockUncover Innoplexus' growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Innoplexus's Competitors and alternates

Top competitors of Innoplexus include AbbVie, Amgen and IQVIA. Here is the list of Top 10 competitors of Innoplexus, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for AbbVie
AbbVie
2012, Chicago (United States), Public
Research-based biopharmaceutical company
$14.7B
81/100
2nd
Logo for Amgen
Amgen
1980, Thousand Oaks (United States), Public
Developer of pharmaceutical products for treating multiple diseases
-
81/100
3rd
Logo for IQVIA
IQVIA
1982, Durham (United States), Public
Provider of clinical research and commercialization solutions for healthcare
$1.74M
80/100
4th
Logo for Gilead
Gilead
1987, Foster City (United States), Acquired
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
-
80/100
5th
Logo for Lilly
Lilly
1876, Indianapolis (United States), Public
Developer of traditional pharmaceutical medicines
-
79/100
6th
Logo for Johnson & Johnson
Johnson & Johnson
1886, New Brunswick (United States), Public
Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products
-
76/100
7th
Logo for AstraZeneca
AstraZeneca
1999, Cambridge (United Kingdom), Public
Developer of pharmaceutical medicines for oncology and various chronic diseases
-
73/100
8th
Logo for Roivant Sciences
Roivant Sciences
2014, New York City (United States), Public
Developer of therapeutics to treat neurology, oncology, rare, and endocrinology based diseases
$1.3B
72/100
9th
Logo for Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
1988, Tarrytown (United States), Public
Developer of antibodies for the treatment of cancer, eye diseases, inflammatory diseases & others
-
71/100
10th
Logo for Novartis
Novartis
1996, Basel (Switzerland), Acquired
R&D focused on manufacturing of drugs for multiple therapeutic areas
-
71/100
125th
Logo for Innoplexus
Innoplexus
2011, Eschborn (Germany), Series C
AI-based life Sciences company that provides solutions for discovering and developing safer and more successful medicines by leveraging its proprietary ontosight AI search platform
-
47/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Innoplexus's competitors? Click here to see the top ones

Innoplexus's Investments and acquisitions

Innoplexus has a total of 1 investment in Docplexus. Innoplexus has not made any acquisitions as of now.

Reports related to Innoplexus

Here is the latest report on Innoplexus's geography:

News related to Innoplexus

lockFilter this list
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Innoplexus

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford